Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03850899 · ClinicalTrials.gov registry record
Alcoholic Hepatitis Network Observational Study
A clinical trial of Alcoholic Hepatitis, sponsored by Indiana University.
- Completed
- Registry status
- 1,133
- Enrollment target
- 9
- Study locations
NCT03850899: Completed study of Alcoholic Hepatitis, sponsored by Indiana University.
NCT03850899 is a study of Alcoholic Hepatitis that has completed, run by Indiana University. The registered enrollment target is 1,133 participants, above the 75-participant average among 5 other Alcoholic Hepatitis trials with a reported enrollment target (1411% higher). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03850899, a study of Alcoholic Hepatitis, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 1,133 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this research study is to create a clinical database and bio-repository. To do this, we will obtain blood, urine, saliva, and stool samples (e.g., biological samples) and personal health information from you to use in future research studies related to alcoholic hepatitis or other diseases. Part of your blood sample will be used to extract your DNA. DNA is the genetic material that gives us unique characteristics. We are doing this research study because we are trying to find out more about how and why illnesses related to alcoholic hepatitis or other diseases occur in people. To do this, we will study the biological samples and personal health information from healthy and sick people. A "biological sample" is usually blood, but can be any body fluid. "Personal Health Information" includes such items as your name, age, gender, race, and/or your medical information. It can also include data from measurements and tests that you had while participating in another research study or that were done during the course of your regular medical care or doctor visits.
Conditions Studied
Study Locations (9)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
- University Of Massachusetts - Worcester
Indiana
- IU School of Medicine - Indianapolis
Kentucky
- University of Louisville - Louisville
Minnesota
- Mayo Clinic - Rochester
Ohio
- Cleveland Clinic - Cleveland
Pennsylvania
- University of Pittsburgh - Pittsburgh
Texas
- University of Texas Southwestern Medical School - Dallas
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,133 participants |
| Start Date | 2019-04-17 |
| Est. Completion | 2024-06-21 |
What the finished NCT03850899 record still lists
NCT03850899 is an observational study that tracks outcomes without assigning an intervention. Its 1,133 participants enrollment target places it among the larger protocols in the corpus, above the 75-participant average among 5 other Alcoholic Hepatitis trials with a reported enrollment target (1411% higher).
The record links to 1 condition, with Alcoholic Hepatitis appearing as the primary indexed condition, and to 0 interventions.
NCT03850899 lists 9 locations in 8 states (Massachusetts, Indiana, Kentucky).
Frequently Asked Questions
What is clinical trial NCT03850899 about?
NCT03850899 is a clinical study titled "Alcoholic Hepatitis Network Observational Study". The purpose of this research study is to create a clinical database and bio-repository. To do this, we will obtain blood, urine, saliva, and stool samples (e.g., biological samples) and personal health information from you to use in future research studies related to alcoholic hepatitis or other dis...
What is the current status of trial NCT03850899?
This trial is currently completed. The enrollment target is 1,133 participants. The study started on 2019-04-17. Estimated completion is 2024-06-21.
What conditions does trial NCT03850899 study?
This clinical trial studies the following conditions: Alcoholic Hepatitis.
Who is sponsoring clinical trial NCT03850899?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03850899 being conducted?
This trial has 9 study locations across Indiana, Kentucky, Massachusetts, Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcoholic Hepatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH
RECRUITING · NA
-
Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis
RECRUITING · Phase 1
-
Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis
RECRUITING
-
HA35 Moderate Alcoholic Hepatitis (AH) Study
RECRUITING · Early Phase 1
-
Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06445062 · 1,130 participants · Phase 1
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- NCT05894967 · 1,140 participants · NA
Moderators and Mediators of Perceptual Learning
- NCT06532487 · 1,140 participants · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
- NCT06746129 · 1,126 participants · Phase 3
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI